TNMD and peripheral arterial disease: For example, tenomodulin was strongly associated with PAD (HR 1.31, 95% CI 1.17 to 1.46), but despite our comprehensive assessment we were only able to explain 4.23% of variation in plasma levels, mainly explained by the trans-pQTL score (1.52%).